Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The firm aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. The company operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. The company offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. The company is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Abattis Bioceuticals Corp의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Generative AI Solutions Corp. 주요 수익원은 Artificial Intelligence and Machine Learning Technology Space이며, 최신 수익 발표에서 수익은 181,757입니다. 지역별로는 Canada이 Generative AI Solutions Corp.의 주요 시장이며, 수익은 181,757입니다.
Abattis Bioceuticals Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Generative AI Solutions Corp.의 순손실은 $0입니다.